Author
Listed:
- Anas A. Khan
(Department of Emergency Medicine, College of Medicine, King Saud University, Global Center for Mass Gatherings Medicine, Ministry of Health, Riyadh 11451, Saudi Arabia
The first two authors contributed equally to this work.)
- Yazed AlRuthia
(Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2454, Riyadh 11451, Saudi Arabia
Pharmacoeconomics Research Unit, College of Pharmacy, King Saud University, P.O. Box 2454, Riyadh 11451, Saudi Arabia
The first two authors contributed equally to this work.)
- Bander Balkhi
(Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2454, Riyadh 11451, Saudi Arabia
Pharmacoeconomics Research Unit, College of Pharmacy, King Saud University, P.O. Box 2454, Riyadh 11451, Saudi Arabia)
- Sultan M. Alghadeer
(Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2454, Riyadh 11451, Saudi Arabia)
- Mohamad-Hani Temsah
(College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia
Department of Pediatrics, King Saud University Medical City, King Saud University, Riyadh 11451, Saudi Arabia)
- Saqer M. Althunayyan
(Department of Accident and Trauma, Prince Sultan Bin Abdulaziz College for Emergency Medical Services, King Saud University, Riyadh 11451, Saudi Arabia)
- Yousef M. Alsofayan
(Global Center for Mass Gatherings Medicine, Ministry of Health, Riyadh 11451, Saudi Arabia)
Abstract
Objectives: Assess the survival of hospitalized coronavirus disease 2019 (COVID-19) patients across age groups, sex, use of mechanical ventilators (MVs), nationality, and intensive care unit (ICU) admission in the Kingdom of Saudi Arabia. Methods: Data were retrieved from the Saudi Ministry of Health (MoH) between 1 March and 29 May 2020. Kaplan–Meier (KM) analyses and multiple Cox proportional-hazards regression were conducted to assess the survival of hospitalized COVID-19 patients from hospital admission to discharge (censored) or death. Micro-costing was used to estimate the direct medical costs associated with hospitalization per patient. Results: The number of included patients with complete status (discharge or death) was 1422. The overall 14-day survival was 0.699 (95%CI: 0.652–0.741). Older adults (>70 years) (HR = 5.00, 95%CI = 2.83–8.91), patients on MVs (5.39, 3.83–7.64), non-Saudi patients (1.37, 1.01–1.89), and ICU admission (2.09, 1.49–2.93) were associated with a high risk of mortality. The mean cost per patient (in SAR) for those admitted to the general Medical Ward (GMW) and ICU was 42,704.49 ± 29,811.25 and 79,418.30 ± 55,647.69, respectively. Conclusion: The high hospitalization costs for COVID-19 patients represents a significant public health challenge. Efficient allocation of healthcare resources cannot be emphasized enough.
Suggested Citation
Anas A. Khan & Yazed AlRuthia & Bander Balkhi & Sultan M. Alghadeer & Mohamad-Hani Temsah & Saqer M. Althunayyan & Yousef M. Alsofayan, 2020.
"Survival and Estimation of Direct Medical Costs of Hospitalized COVID-19 Patients in the Kingdom of Saudi Arabia,"
IJERPH, MDPI, vol. 17(20), pages 1-12, October.
Handle:
RePEc:gam:jijerp:v:17:y:2020:i:20:p:7458-:d:427504
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Mihai Popescu & Oana Mara Ştefan & Mihai Ştefan & Liana Văleanu & Dana Tomescu, 2022.
"ICU-Associated Costs during the Fourth Wave of the COVID-19 Pandemic in a Tertiary Hospital in a Low-Vaccinated Eastern European Country,"
IJERPH, MDPI, vol. 19(3), pages 1-11, February.
- Antonio Lopez-Villegas & Rafael Jesus Bautista-Mesa & Pedro Acosta-Robles & David Hidalgo-Serrano & Francisco Javier Aguirre-Ortega & Miguel Angel Castellano-Ortega & Maria Marta Mollo & Cesar Leal-Co, 2022.
"Analysis of Healthcare Costs Incurred in Regional Hospitals in Andalusia (Spain) during the COVID-19 Pandemic,"
IJERPH, MDPI, vol. 19(23), pages 1-11, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:20:p:7458-:d:427504. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.